Antiplatelet agents and extracorporeal circulation.
D011464:Epoprostenol / Q000627:therapeutic use*; D005112:Extracorporeal Circulation / Q000009:adverse effects; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000627:therapeutic use*; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*
D011453:Prostaglandins; D006493:Heparin; D011464:Epoprostenol; D013442:Sulfinpyrazone